CRA Insights: Life Sciences
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share an update on a Supreme Court...
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Engagements
- 01Cigna-Anthem Merger LitigationCRA was retained by counsel for Cigna Corporation in a litigation in Delaware Chancery Court arising from its unsuccessful merger with Anthem, Inc. Both...View engagement
- 02CRA experts testify in civil antitrust trial involving alleged tying of PICC lines and location devicesOn October 3, 2022, CRA experts testified on behalf of C.R. Bard in AngioDynamics, Inc. v. C.R. Bard, Inc. et al. in the Northern District of New York....View engagement
- 03CRA experts advise on oncology, consumer health, and animal health transactions before FTCCRA advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint venture with...View engagement
Meet our team
![Gregory Bell | Expert Witness | Charles River Associates]()
Gregory K. BellGroup Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.com![Peter Rankin Life Sciences Litigation Charles River Associates]()
![Andrew Tepperman | Life Sciences Litigation | Charles River Associates]()
Recent events
GAR Webinar: Collaboration Agreements in Life Sciences - International Arbitration Issues
International arbitration is a common mechanism for resolution of the complex, cross-border disputes that can plague global collaborations in life sciences. ...
Licensing Executives Society 2021 Royalty Rates & Deal Terms Survey Presentation
Sean Sheridan co-presents an overview of the Licensing Executives Society 2021 Royalty Rates & Deal Terms Survey with LES during a private BIO International...